The 2025 regulations amended the 2018 Branded Health Service Medicines (Costs) Regulations by changing payment percentages for branded medicines and adjusting the auditing process for presentation reports.

The Branded Health Service Medicines (Costs) (Amendment) Regulations 2025 modify the 2018 regulations governing payments from manufacturers and suppliers of branded medicines.

Key changes include altering payment percentages for different periods and updating auditing requirements for presentation reports, allowing an alternative 'agreed upon' procedure instead of a full audit.

The amendments aim to improve efficiency, ensure fair payment, and streamline administrative processes.

The regulations amended the Communications Act 2003, delaying the effective date of restrictions on advertising less healthy food and drink to January 5, 2026.

These regulations amend the Communications Act 2003, delaying the implementation of restrictions on the advertising of less healthy food and drink.

The effective date is pushed back from October 1, 2025, to January 5, 2026.

The changes affect several sections of the Act, specifically those outlining the objectives for such advertisements and the prohibition of paid advertising for less healthy food and drink.

An explanatory note references a full impact assessment conducted previously, explaining the lack of a new assessment for this amendment.

Amendments were made to regulations governing NHS charges, remission of charges, pharmaceutical services, and pre-payment certificates, primarily related to tax credit changes, distance selling pharmacies, and improved refund processes.

The 2025 National Health Service regulations amend three existing sets of regulations: those concerning travel expenses and remission of charges, pharmaceutical and local pharmaceutical services, and charges for drugs and appliances.

Key changes include removing tax credit-based exemptions from charges, updating rules for distance-selling pharmacies, and introducing automated refunds for pre-payment certificates for those becoming eligible for exemptions.

The amendments aim to streamline processes, update services, and address policy shift related to the termination of tax credits.

The regulations amended the Whiplash Injury Regulations 2021, increasing the compensation amounts for whiplash injuries based on injury duration, effective May 31st, 2025.

The Whiplash Injury (Amendment) Regulations 2025, effective May 31st, 2025, amend the 2021 regulations governing compensation for whiplash injuries from road traffic accidents in England and Wales.

The amendments introduce two new tables specifying increased damage amounts based on injury duration.

Table 1 applies to cases arising before May 31st, 2025, and Table 2 applies to those arising on or after that date.

The changes reflect adjustments to damage amounts, likely linked to inflation, and were approved by Parliament.

This document amended the Legal Aid, Sentencing and Punishment of Offenders Act 2012 and related secondary legislation to update and expand access to legal aid in relation to cases involving domestic abuse.

This Order modifies the Legal Aid, Sentencing and Punishment of Offenders Act 2012 to expand legal aid access for domestic abuse cases.

It broadens the definition of 'domestic abuse,' replaces outdated terms like 'domestic violence' with the modern terminology, and extends coverage to encompass numerous procedures connected to domestic abuse protection orders.

Furthermore, the Order adjusts related civil and criminal legal aid regulations to ensure consistency and effectiveness in providing aid.

The 2025 regulations amended UK legislation to remove Dechlorane Plus and UV-328 from the list of controlled persistent organic pollutants.

The Persistent Organic Pollutants (Amendment) (No. 3) Regulations 2025 amend Regulation (EU) 2019/1021, removing Dechlorane Plus and UV-328 from Annex 1's list of controlled substances.

The regulations were enacted by the Secretary of State with consent from the Scottish and Welsh Ministers and came into force immediately upon enactment.

An impact assessment is available online.

The 2025 regulations amended the 2002 Medical Devices Regulations by removing certain EU law revocation dates.

The Medical Devices (Amendment) (Great Britain) Regulations 2025 amend the 2002 Medical Devices Regulations by removing specific revocation dates for assimilated EU laws.

This action maintains the existing regulatory framework for medical devices in Great Britain, ensuring public health safety, by removing now unnecessary dates for the revocation of several EU regulations.

The regulations came into force on May 24, 2025, applying to England, Wales, and Scotland.

Specific sections of the Genetic Technology (Precision Breeding) Act 2023 relating to precision-bred plants were brought into force in England, Wales, and Scotland.

These regulations, effective November 13, 2025, activate parts of the Genetic Technology (Precision Breeding) Act 2023.

The Act governs the release and sale of precision-bred organisms, specifically focusing on plants within England, Wales, and Scotland.

The regulations specify which sections of the Act come into force, primarily those concerning the release, marketing, risk assessment, and production of food from precision-bred plants, and their enforcement.